Iodeto De Sódio [i 131] T Curium Netherlands

Sodium Iodide (I-131), the active ingredient in Iodeto De Sódio [i 131] T Curium Netherlands, is a radioactive iodine preparation presented as an oral formulation for systemic use. It is employed in the management of thyroid cancer, hyperthyroidism and for thyroid tissue ablation after surgery.

GNH USA supplies Iodeto De Sódio [i 131] T Curium Netherlands as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iodeto De Sódio (Sodium Iodide I-131) is used in conditions that involve thyroid tissue where radioactive iodine can be taken up.

Thyroid cancer: helps destroy residual thyroid cells and metastatic disease after surgery. Hyperthyroidism: reduces overactive thyroid tissue by delivering targeted radiation. Thyroid ablation: eliminates remaining thyroid tissue prior to radioactive iodine therapy or to prepare for hormone replacement.

Adverse reactions may occur following oral administration of radioactive iodine.

Common Side Effects: - Nausea or upset stomach. - Dry mouth or altered taste sensation. - Transient neck discomfort or mild thyroiditis.

Serious or Rare Side Effects: - Bone marrow suppression leading to cytopenias. - Severe radiation thyroiditis with significant swelling. - Secondary malignancies such as leukemia. - Allergic reactions including rash or anaphylaxis. - Pulmonary fibrosis (very rare).

Careful assessment is required before prescribing radioactive iodine. - Pregnancy: avoid use unless benefits clearly outweigh risks. - Breastfeeding: discontinue treatment and advise cessation of nursing. - Renal impairment: monitor renal function and adjust monitoring frequency. - Concurrent thyroid hormone therapy: may need dose adjustment. - Radiation safety: limit exposure to family members and follow shielding guidelines. - Store at ambient temperature: keep in original container, protect from moisture and light.

Radioactive iodine can interact with several medications that affect thyroid uptake or radiation exposure.

Major Interactions (Avoid): - Thyroid hormone suppressive therapy: may reduce iodine uptake. - Lithium: increases retention of I-131 in thyroid tissue. - Antithyroid drugs (propylthiouracil, methimazole): block iodine uptake.

Moderate Interactions (Monitor Closely): - Diuretics: may alter renal clearance of iodine. - ACE inhibitors: require monitoring of renal function. - Other radiopharmaceuticals: cumulative radiation dose should be evaluated.